
Homepage - Staar Surgical
STAAR designs, develops, manufactures and markets implantable lenses for the eye with companion delivery systems. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses.
STAAR Surgical Company - Home
Mar 5, 2025 · STAAR, which has been dedicated solely to ophthalmic surgery for over 40 years, designs, develops, manufactures and markets implantable lenses for the eye. These lenses are intended to provide visual freedom for patients, lessening or …
EVO ICL™ - Staar Surgical
STAAR® Surgical's phakic IOL for myopia and astigmatism EVO is an Evolution in Visual Freedom designed to provide premium refractive outcomes while optimizing patient comfort. Made from Collamer®, EVO can treat a wide range of refractive error.
Staar Surgical names Stephen Farrell as CEO | MedTech Dive
Mar 4, 2025 · Staar Surgical named lead independent director Stephen Farrell as president and CEO, replacing Tom Frinzi. The maker of implantable lenses for vision correction said Frinzi, CEO since January 2023 , will remain in an advisory role through January 2026 to support the leadership transition.
STAAR Surgical Announces Leadership Transition
Feb 26, 2025 · Stephen C. Farrell appointed CEO to succeed Tom Frinzi Elizabeth Yeu, M.D. elected Board Chair STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced a leadership transition.
STAAR Surgical Company - STAAR Surgical Announces U.S. FDA …
Mar 5, 2025 · LAKE FOREST, Calif.--(BUSINESS WIRE)-- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that the U.S. Food and Drug Administration (FDA) has granted approval of the EVO/EVO+ Visian® Implantable Collamer® Lens (“EVO”) for ...
Staar Surgical Appoints New CEO Amid Declining China Sales
5 days ago · Shares of Staar Surgical Co. dropped 25% on Feb. 11 after it surprised Wall Street when it reported fourth quarter sales falling 36% to $49 million. Two weeks later, the Lake Forest-based maker of implantable lenses announced Tom Frinzi was out after two years as chief executive and three years as chairman.
STAAR Surgical - LinkedIn
STAAR Surgical | 40,811 followers on LinkedIn. STAAR designs, develops, manufactures and markets implantable lenses for the eye and companion delivery systems.
STAAR Surgical Company (STAA)
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the...
Our Mission - Staar Surgical
STAAR designs, develops, manufactures and markets implantable lenses for the eye and companion delivery systems. These lenses are intended to provide visual freedom to patients, lessening or eliminating the reliance on glasses or contact lenses.
- Some results have been removed